Market open
Synlogic Inc./$SYBX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
Ticker
$SYBX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
1
ISIN
US87166L2097
Website
Synlogic Inc. Metrics
BasicAdvanced
$13M
5.25
$0.21
-
-
Price and volume
Market cap
$13M
52-week high
$1.41
52-week low
$0.90
Average daily volume
14K
Financial strength
Current ratio
3.677
Quick ratio
3.544
Management effectiveness
Return on assets (TTM)
-14.07%
Return on equity (TTM)
19.41%
Valuation
Price to earnings (TTM)
5.251
Price to book
1.01
Price to tangible book (TTM)
1.01
Price to free cash flow (TTM)
-0.772
Growth
Revenue change (TTM)
-100.00%
Earnings per share change (TTM)
-102.47%
3-year earnings per share growth (CAGR)
-75.72%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Synlogic Inc. stock?
Synlogic Inc. (SYBX) has a market cap of $13M as of May 14, 2025.
What is the P/E ratio for Synlogic Inc. stock?
The price to earnings (P/E) ratio for Synlogic Inc. (SYBX) stock is 5.25 as of May 14, 2025.
Does Synlogic Inc. stock pay dividends?
No, Synlogic Inc. (SYBX) stock does not pay dividends to its shareholders as of May 14, 2025.
When is the next Synlogic Inc. dividend payment date?
Synlogic Inc. (SYBX) stock does not pay dividends to its shareholders.
What is the beta indicator for Synlogic Inc.?
Synlogic Inc. (SYBX) does not currently have a Beta indicator.